| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 22,400 | 23,700 | 23.06. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.06. | BASTIDE: Completion of the disposal of New Medical Concept, the holding company of EXPERF Group, to Sapio Group | 338 | Actusnews Wire | Caissargues, 1st June 2026 - Bastide Group announces the completion of the acquisition by Sapio Group of its subsidiary New Medical Concept, the holding company of the French EXPERF Group, a specialist... ► Artikel lesen | |
| 21.05. | BASTIDE: Groupe Bastide sells New Medical Concept, the holding company of EXPERF group - Erratum | 452 | Actusnews Wire | Caissargues, 21 May 2026 -Groupe Bastide today announced the signing of an agreement for the disposal of its subsidiary New Medical Concept, the holding company of the French group EXPERF, specialized... ► Artikel lesen | |
| BASTIDE LE CONFORT MEDICAL Aktie jetzt für 0€ handeln | |||||
| 21.05. | BASTIDE: Groupe Bastide sells New Medical Concept, the holding company of EXPERF group | 399 | Actusnews Wire | Caissargues, 21 May 2026 -Groupe Bastide today announced the signing of an agreement for the disposal of its subsidiary New Medical Concept, the holding company of the French group EXPERF, specialized... ► Artikel lesen | |
| 13.05. | BASTIDE: Strong momentum for the first nine months of the financial year: up 7.2% on an organic basis | 686 | Actusnews Wire | Sustained growth in home healthcare services: up 8.5%
Solid growth of 5.2% in Homecare, including the one-off impact of the VPH* reform in the third quarter
2025-2026 targets confirmed
Caissargues... ► Artikel lesen | |
| 18.03. | BASTIDE: 2025-2026 half-year results | 1.019 | Actusnews Wire | Recurring operating margin: 9.0%, in line with the annual target
Operating profit up 12.5%
Operating free cash flow: €24.3 million, a threefold increase in one year
Significant improvement... ► Artikel lesen | |
| 12.02. | BASTIDE: Organic growth of 8.2% in first-half 2025-2026: Confirmed excellent growth momentum in home healthcare services: 9.2% / Accelerated growth in the Homecare business, up 6.5% // 2025-2026 targets confirmed | 475 | Actusnews Wire | Caissargues, February 12, 2026 - Groupe Bastide, a leading European provider of home healthcare services, has published its revenue for first-half 2025-2026, ending December 31, 2025.
In... ► Artikel lesen | |
| 13.11.25 | BASTIDE: Organic growth of 8.3% in first-quarter 2025-2026: Sustained growth in home healthcare services, up 10.7% / Homecare business up 4.7%, driven by the healthcare institutions business (up 8.5%) | 534 | Actusnews Wire | Caissargues, November 13, 2025 - Groupe Bastide, a leading European provider of home healthcare services, has published its revenue for first-quarter 2025-2026, ending September 30, 2025.
In... ► Artikel lesen | |
| 28.10.25 | BASTIDE: 2025-2026 financial calendar | 1.061 | Actusnews Wire | Caissargues, October 28, 2025
Events
Dates*
2025-2026 Q1 Revenue
Thursday November 13, 2025
2025-2026 H1 Revenue
Thursday February 12, 2026
2025-2026 H1 Results
Wednesday... ► Artikel lesen | |
| 22.10.25 | BASTIDE: 2024-2025 annual results in line with targets // 2025-26 outlook: Revenue of over EUR 510 million and recurring operating margin around 9%, Leverage of less than 3x and decrease in financial expenses | 943 | Actusnews Wire | Caissargues, October 22, 2025 - Groupe Bastide, a leading European provider of home healthcare services, has announced its 2024-2025 annual results at June 30, 2025. The 2024-2025 annual consolidated... ► Artikel lesen | |
| 24.09.25 | BASTIDE: Groupe Bastide completes the sale of Baywater Healthcare to Sapio Group | 843 | Actusnews Wire | Caissargues, September 24, 2025
In line with the timetable set out in its 30 June 2025 communication announcing the agreement to sell Baywater Healthcare, a leading player in the UK respiratory... ► Artikel lesen | |
| 04.09.25 | BASTIDE: 2024-2025 revenue target met // 2024-2025 revenue from continuing operations: EUR 491 million, up 8% ( EUR 561 million, excluding impact of disposals) | 613 | Actusnews Wire | Caissargues, September 4, 2025
Groupe Bastide has published its annual revenue for 2024-2025. In accordance with IFRS 5, reported revenue relates exclusively to continuing operations, and no... ► Artikel lesen | |
| 30.06.25 | BASTIDE: Bastide Groupe Sells Baywater Healthcare To Sapio Group | 787 | Actusnews Wire | Crewe, United Kingdom & Monza, Italy - 30th June 2025
Bastide le Confort Medical SA (hereinafter "Groupe Bastide") today announced that it has agreed to the sale of its subsidiary Baywater Healthcare... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ANSELL | 18,100 | -1,09 % | Ansell Names Erik Van Den Enden CFO With Effect From Sept. 1 | CANBERA (dpa-AFX) - Australian safety products maker Ansell Ltd. (ANN.AX) announced on Monday that it has appointed Erik Van den Enden as chief financial officer, effective September 1.Van den... ► Artikel lesen | |
| AMBEA | 11,870 | -0,67 % | Ambea AB: Ambea strengthens its offering within child and youth care through an acquisition in Finland | Ambea has, through its Finnish business area Validia, signed an agreement to acquire the business operations of Ehot Ltd. The acquisition covers child and youth care services in Finland, focusing on... ► Artikel lesen | |
| FRESENIUS | 39,900 | +0,91 % | DAX-Check LIVE: Auto1, BMW, Fresenius, Munich Re, Vonovia im Fokus | Der deutsche Aktienmarkt hat den Dienstag nur mit einem Mini-Plus beendet. Der DAX, der am Morgen noch über 25.100 Punkten notiert hatte, schloss am Ende lediglich 0,07 Prozent fester bei 24.910 Zählern.... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,550 | +0,73 % | 3 Charts in 3x33 Sekunden - Heute mit Intel, Dow Jones und FMC | 3 Charts in 3x33 Sekunden - Heute mit Intel, Dow Jones und FM ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 34,520 | +0,06 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 66,83 | -0,55 % | BrightSpring Health Services, Inc. Reports First Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., May 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| BETA BIONICS | 13,670 | -0,22 % | Beta Bionics, Inc.: Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| HEARTSCIENCES | 2,750 | +55,37 % | Fortitude Mining Holdings, Inc. and HeartSciences Inc. Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets | FAIRPORT, N.Y.--(BUSINESS WIRE)--Fortitude Mining Holdings, Inc. ("Fortitude"), a vertically-integrated digital asset mining platform anchored in Zcash, and HeartSciences Inc. (Nasdaq: HSCS) ("HeartSciences")... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 26,940 | -1,75 % | DAX-Check LIVE: Brenntag, Carl Zeiss Meditec, DWS, Infineon, RWE, Vonovia im Fokus | Der deutsche Aktienmarkt hat den Wochenauftakt mit Gewinnen beendet. Der DAX schloss 0,6 Prozent fester bei 25.139 Punkten und verteidigte damit erneut die psychologisch wichtige Marke von 25.000 Zählern.... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,645 | +1,67 % | Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation | ORANGE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced leadership updates that further strengthen the organization as the company continues to scale... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 20,600 | -2,18 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GENEDX | 58,02 | +4,69 % | Piper Sandler raises GeneDx stock price target on coverage policy | ||
| HEARTFLOW | 34,450 | +1,80 % | Heartflow, Inc. - 8-K, Current Report | ||
| GERRESHEIMER | 27,400 | +5,79 % | EQS-PVR: Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Gerresheimer AG
Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
22.06.2026 / 11:08 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| PROGYNY | 26,610 | +1,26 % | Truist raises Progyny stock price target to $33 on growth outlook |